These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 3037722

  • 1. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
    Williams S, Gralnick H.
    Thromb Res; 1987 May 01; 46(3):457-71. PubMed ID: 3037722
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of platelet-von Willebrand factor binding to platelets by adhesion site peptides.
    Parker RI, Gralnick HR.
    Blood; 1989 Sep 01; 74(4):1226-30. PubMed ID: 2548639
    [Abstract] [Full Text] [Related]

  • 3. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
    Bennett JS, Shattil SJ, Power JW, Gartner TK.
    J Biol Chem; 1988 Sep 15; 263(26):12948-53. PubMed ID: 3417645
    [Abstract] [Full Text] [Related]

  • 4. Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb-IIIa.
    Ando B, Wiedmer T, Hamilton KK, Sims PJ.
    J Biol Chem; 1988 Aug 25; 263(24):11907-14. PubMed ID: 3261296
    [Abstract] [Full Text] [Related]

  • 5. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR, Williams SB, Coller BS.
    J Clin Invest; 1985 Jan 25; 75(1):19-25. PubMed ID: 2981249
    [Abstract] [Full Text] [Related]

  • 6. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets.
    Mohri H, Ohkubo T.
    Thromb Haemost; 1993 May 03; 69(5):490-5. PubMed ID: 8322271
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D, Lider O, Dardik R, Shenkman B, Alon R, Hershkoviz R, Kapustina G, Savion N, Martinowitz U, Greenspoon N.
    Thromb Haemost; 1993 Dec 20; 70(6):1030-6. PubMed ID: 8165596
    [Abstract] [Full Text] [Related]

  • 8. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E, Lévy-Toledano S, Rendu F, Hermant L, Lu H, Fiat AM, Jollès P, Caen J.
    Eur J Biochem; 1990 Nov 26; 194(1):43-9. PubMed ID: 2174781
    [Abstract] [Full Text] [Related]

  • 9. Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis.
    Beacham DA, Wise RJ, Turci SM, Handin RI.
    J Biol Chem; 1992 Feb 15; 267(5):3409-15. PubMed ID: 1737795
    [Abstract] [Full Text] [Related]

  • 10. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation.
    Chow TW, Hellums JD, Moake JL, Kroll MH.
    Blood; 1992 Jul 01; 80(1):113-20. PubMed ID: 1611079
    [Abstract] [Full Text] [Related]

  • 11. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Gartner TK, Bennett JS.
    J Biol Chem; 1985 Oct 05; 260(22):11891-4. PubMed ID: 2995350
    [Abstract] [Full Text] [Related]

  • 12. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF, Liu CZ, Ouyang CH, Teng CM.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1209-19. PubMed ID: 1888330
    [Abstract] [Full Text] [Related]

  • 13. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
    Timmons S, Kloczewiak M, Hawiger J.
    Proc Natl Acad Sci U S A; 1984 Aug 22; 81(15):4935-9. PubMed ID: 6087354
    [Abstract] [Full Text] [Related]

  • 14. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L, Girolami A, Zimmerman TS, Ruggeri ZM.
    Proc Natl Acad Sci U S A; 1985 Nov 22; 82(21):7424-8. PubMed ID: 2932740
    [Abstract] [Full Text] [Related]

  • 15. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa.
    Parise LV, Helgerson SL, Steiner B, Nannizzi L, Phillips DR.
    J Biol Chem; 1987 Sep 15; 262(26):12597-602. PubMed ID: 2957377
    [Abstract] [Full Text] [Related]

  • 16. Modulation of an RGDS binding site on the platelet membrane glycoprotein IIb-IIIa complex.
    Santoro SA, Lawing WJ.
    Biochem Biophys Res Commun; 1989 Apr 14; 160(1):189-95. PubMed ID: 2712830
    [Abstract] [Full Text] [Related]

  • 17. Endogenous platelet fibrinogen surface expression on activated platelets.
    Gralnick HR, Williams S, McKeown L, Connaghan G, Shafer B, Hansmann K, Vail M, Fenton J.
    J Lab Clin Med; 1991 Dec 14; 118(6):604-13. PubMed ID: 1744509
    [Abstract] [Full Text] [Related]

  • 18. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering.
    Isenberg WM, McEver RP, Phillips DR, Shuman MA, Bainton DF.
    J Cell Biol; 1987 Jun 14; 104(6):1655-63. PubMed ID: 3584243
    [Abstract] [Full Text] [Related]

  • 19. Synthetic peptides demonstrate RGD-independent platelet glycoprotein IIb/IIIa recognition site in cell binding domain of human fibronectin.
    Mohri H, Tanabe J, Katoh K, Okubo T.
    Peptides; 1995 Jun 14; 16(2):263-8. PubMed ID: 7784256
    [Abstract] [Full Text] [Related]

  • 20. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
    De Marco L, Girolami A, Zimmerman TS, Ruggeri ZM.
    J Clin Invest; 1986 Apr 14; 77(4):1272-7. PubMed ID: 3007578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.